Clinical trial NCT04906681: Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: an Exploratory Study
Official title: Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: an Exploratory Study
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: PHASE1
PHASE2
Conditions: Arthroplasty
Neurologic Disorder
Keywords: rehabilitation
technology
Lead sponsor: PXL University College
Sponsor class: OTHER
Collaborators: name: St-Trudo hospital, St-Truiden, Belgium
First posted: 2021-05-28
Enrollment: 40
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Rehabilitation technology is more and more implemented in conventional therapy to increase the dosage of therapy and/or increase patient's motivation towards therapy. In orthopedic as well as neurological rehabilitation it is important to exercise with enough intensity and repetitions to improve functional performance in activities of daily life, and consequently quality of life. At the moment, not all (rehabilitation) technologies are adapted towards the wishes and needs of both patients and therapists for everyday use in the clinical setting. Also, not all technologies are fit for independent use by the patients. Researcher of PXL have developed a Kinect-based system (i.e. i-ACT) for rehabilitation and performed supervised research with i-ACT in neurological and musculoskeletal rehabilitation, and older adults. Within this research, patients will exercise with i-ACT under supervision of their therapist during weekdays, but in the weekends they will be motivated by the medical staff to perform their exercises with i-ACT. The medical staff will be present for safety reasons, but the patient is asked to use and exercise with i-ACT as independent as possible. The aim of this research is to explore to which extend i-ACT is suitable for semi-independent use by patients in orthopedic or neurological rehabilitation.


Eligibility criteria: Inclusion Criteria:

* age over 18 years old
* post-operation of arthroplasty (hip or knee), or official medical diagnosis of stroke or Parkinson's disease
* understand Dutch instructions
* patient at St-Trudo ziekenhuis
* experiencing problems in functional performance

Exclusion Criteria:

* neglect
* spasticity (Brunström Fugl-Meyer \< 50)
* cognitive disfunction (Mini Mental State Examination \< 24)
* visual impairment (blind, cataract, etc.)
* persons who are not able to exit electric wheelchair

Primary outcomes:
measure: Canadian Occupational Performance Measure
timeFrame: Baseline
measure: Canadian Occupational Performance Measure
timeFrame: 4 weeks
Secondary outcomes:
measure: Intrinsic Motivation Inventory
timeFrame: 1 week
measure: Intrinsic Motivation Inventory
timeFrame: 4 weeks
measure: System Usability Scale
timeFrame: 1 week
measure: System Usability Scale
timeFrame: 4 weeks
measure: Timed Up and Go test
timeFrame: Baseline
measure: Timed Up and Go test
timeFrame: 4 weeks
measure: 2 Minute Walking Test
timeFrame: Baseline
measure: 2 Minute Walking Test
timeFrame: 4 weeks
measure: Wolf Motor Function Test
timeFrame: Baseline
measure: Wolf Motor Function Test
timeFrame: 4 weeks
measure: Barthel Index
timeFrame: Baseline
measure: Barthel Index
timeFrame: 4 weeks
Other outcomes:
Locations:
Study officials:
References: